Intuitive Surgical (NASDAQ:ISRG) EVP Brian Edward Miller Sells 3,500 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the sale, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $0.28 during trading on Wednesday, reaching $572.45. The stock had a trading volume of 1,632,272 shares, compared to its average volume of 2,121,198. The business has a fifty day moving average price of $476.01 and a 200-day moving average price of $502.00. The stock has a market cap of $205.21 billion, a PE ratio of 75.72, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Tobam lifted its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in Intuitive Surgical in the second quarter worth about $27,000. Princeton Global Asset Management LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth about $30,000. TD Capital Management LLC lifted its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. Finally, Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Wells Fargo & Company raised their price target on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Finally, Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.